UG Healthcare Corporation Limited (SGX:8K7)

UG Healthcare Corporation Statistics

Total Valuation

SGXC:8K7 has a market cap or net worth of SGD 61.13 million. The enterprise value is 82.78 million.

Market Cap	61.13M
Enterprise Value	82.78M

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

SGXC:8K7 has 623.83 million shares outstanding.

Current Share Class	623.83M
Shares Outstanding	623.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.74%
Owned by Institutions (%)	2.99%
Float	216.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.38
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.79, with an EV/FCF ratio of -13.68.

EV / Earnings	-20.21
EV / Sales	0.57
EV / EBITDA	28.79
EV / EBIT	n/a
EV / FCF	-13.68

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.30.

Current Ratio	2.70
Quick Ratio	1.35
Debt / Equity	0.30
Debt / EBITDA	16.26
Debt / FCF	-7.83
Interest Coverage	-0.37

Financial Efficiency

Return on equity (ROE) is -2.90% and return on invested capital (ROIC) is -0.24%.

Return on Equity (ROE)	-2.90%
Return on Assets (ROA)	-0.22%
Return on Invested Capital (ROIC)	-0.24%
Return on Capital Employed (ROCE)	-0.44%
Revenue Per Employee	172,131
Profits Per Employee	-4,895
Employee Count	837
Asset Turnover	0.62
Inventory Turnover	1.74

Taxes

In the past 12 months, SGXC:8K7 has paid 979,000 in taxes.

Income Tax	979,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.95% in the last 52 weeks. The beta is 0.76, so SGXC:8K7's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-16.95%
50-Day Moving Average	0.10
200-Day Moving Average	0.11
Relative Strength Index (RSI)	44.40
Average Volume (20 Days)	201,230

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:8K7 had revenue of SGD 144.07 million and -4.10 million in losses. Loss per share was -0.01.

Revenue	144.07M
Gross Profit	34.74M
Operating Income	-815,000
Pretax Income	-3.74M
Net Income	-4.10M
EBITDA	2.30M
EBIT	-815,000
Loss Per Share	-0.01

Balance Sheet

The company has 23.29 million in cash and 47.36 million in debt, giving a net cash position of -24.07 million or -0.04 per share.

Cash & Cash Equivalents	23.29M
Total Debt	47.36M
Net Cash	-24.07M
Net Cash Per Share	-0.04
Equity (Book Value)	160.33M
Book Value Per Share	0.26
Working Capital	87.01M

Cash Flow

In the last 12 months, operating cash flow was -2.90 million and capital expenditures -3.16 million, giving a free cash flow of -6.05 million.

Operating Cash Flow	-2.90M
Capital Expenditures	-3.16M
Free Cash Flow	-6.05M
FCF Per Share	-0.01

Margins

Gross margin is 24.11%, with operating and profit margins of -0.57% and -2.84%.

Gross Margin	24.11%
Operating Margin	-0.57%
Pretax Margin	-2.60%
Profit Margin	-2.84%
EBITDA Margin	1.60%
EBIT Margin	-0.57%
FCF Margin	n/a

Dividends & Yields

SGXC:8K7 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.70%
FCF Yield	-9.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 3.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	3

Scores

SGXC:8K7 has an Altman Z-Score of 2.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.64
Piotroski F-Score	2